Sep. 10 at 4:40 PM
$LPCN yes it’s the toughest hold for now. Once 2026 hits, we will be route to get results phase 2B part 1 for obesity drug and then the 1154 results depression + anxiety (500m+ valuation, based on sage aquisition). We can grab at least 50 pct of that we would be solid. Just have to wait. It’s a purely business play, science has always been the bright spot, despite some fda hiccups. Just continue to accumulate and hold. We also know it tends to run up about 6 months prior to results. So maybe December ish or earlier. They manage cash well, I entrust if they’re planning on running 2401, even with our Low cash, there must be some confidence to get some funding - partnership? Private placement?
We know they make their money go the distance And careful with it.
